Investment Thesis
Green Planet Bio Engineering exhibits severe financial distress with negative stockholders' equity of -$501K, zero reportable assets, and zero cash reserves, indicating technical insolvency. The company generates no revenue, reports continuous operating losses (-$35.8K), and negative free cash flow, with liabilities of $283.6K covering assets that are essentially non-existent, making the company unable to meet current financial obligations.
Strengths
- Financial data transparency available via SEC filings
- SIC classification indicates biotech/biological products sector
- Company maintains OTC exchange listing
Risks
- Negative stockholders equity of -$501K indicates technical insolvency
- Total assets reported at $0.00 with $283.6K in liabilities
- Zero cash and equivalents with $0.00 current ratio - unable to pay current liabilities
- No reportable revenue despite biotech sector focus
- Negative operating and free cash flow (-$36.5K) with no path to profitability
- Zero insider Form 4 filings in 90 days indicates no management confidence
- Characteristics suggest potential shell company or defunct operations
Key Metrics to Watch
- Balance sheet restructuring or debt forgiveness announcements
- Achievement of any positive revenue or gross revenue figures
- Capital infusion or financing events to restore positive equity
- Changes in asset base and cash position in next filing
Financial Metrics
Revenue
N/A
Net Income
-35.8K
EPS (Diluted)
$0.00
Free Cash Flow
-36.5K
Total Assets
0.0
Cash
0.0
Profitability Ratios
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
ROE
N/A
ROA
N/A
FCF Margin
N/A
Balance Sheet & Liquidity
Current Ratio
0.00x
Quick Ratio
0.00x
Debt/Equity
N/A
Debt/Assets
0.0%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-10T16:57:19.513388 |
Data as of: 2025-12-31 |
Powered by Claude AI